industry biotechnology headquarters louisville colorado united states number of employees 22 dec 2014 1 website globeimmune.com globeimmune inc. is a clinical stage public biopharmaceutical company headquartered in louisville colorado that develops therapeutic vaccines to treat cancer and infectious diseases . 2 as of august 2014 update the company had no marketed products . 3 globeimmune s therapeutic vaccines are developed on the company s tarmogen immunotherapy platform . tarmogens are made from genetically modified yeast that express one or more disease associated antigens . tarmogens activate t cells to specifically target and eliminate diseased cells with the same target antigen . tarmogen platform the company has partnerships with celgene established in 2009 2 and the national cancer institute for the development of cancer vaccines 4 5 and with gilead for the development of therapeutic vaccines for the treatment of hepatitis b. 6 with respect to financing in the absence of revenue the company raised us 17 500 000 through a series e preferred stock offering in january 2010 . 2 as of august 2015 update globeimmune had two therapeutic vaccines in clinical trials gi 6207 and gi 6301 for the treatment of various cancers . 7 completed trials have addressed two other candidates gi 4000 the company s lead oncology candidate as of 2010 2 and gi 5005 . 7 despite there being three ongoing trials in july 2015 the company announced it would eliminate most of its workforce positions shortly following the failure of a trial examining gi 4774 . 1 references edit a b staff july 2015 . globeimmune authorizes laying off most of its workforce . industry watch . genetic engineering & biotechnology news paper format requires url help . 35 13 . p. 8 . a b c d staff 19 january 2010 . globeimmune raises 17.5 m in series e financing . genetic engineering & biotechnology news . retrieved 2015 08 19 . about globeimmune pdf . globeimmune . 22 august 2014 . retrieved 2015 08 19 . self published source globeimmune and celgene corporation announce strategic global press release . celgene . 15 may 2009 via bloomberg . staff 16 april 2009 . globeimmune starts cancer drug trial . bizwest . colorado united states bizwest media . avery greg 24 october 2011 . globeimmune gilead team up on hepatitis b treatment . denver business journal . a b search of globeimmune . clinicaltrials.gov . united states national institutes of health . external links edit globeimmune website retrieved from https en.wikipedia.org w index.php title globeimmune & oldid 684635900 categories biotechnology companies of the united statescompanies listed on nasdaqhidden categories pages using citations with format and no urlaccuracy disputes from august 2015articles containing potentially dated statements from august 2014all articles containing potentially dated statementsarticles containing potentially dated statements from august 2015 navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 7 october 2015 at 21 05 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view